AAAAAA

   
Results: 1-25 | 26-29
Results: 1-25/29
PATHOGENETIC IMPLICATIONS OF HYALURONAN-INDUCED MODIFICATION OF VASCULAR SMOOTH-MUSCLE CELL FIBRINOLYSIS IN DIABETES
Authors: MARUTSUKA K WOODCOCKMITCHELL J SAKAMOTO T SOBEL BE FUJII S
Citation: K. Marutsuka et al., PATHOGENETIC IMPLICATIONS OF HYALURONAN-INDUCED MODIFICATION OF VASCULAR SMOOTH-MUSCLE CELL FIBRINOLYSIS IN DIABETES, Coronary artery disease, 9(4), 1998, pp. 177-184
TUMOR-NECROSIS-FACTOR-ALPHA AND INSULIN INDUCE PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 IN ADIPOCYTES
Authors: SAKAMOTO T WOODCOCKMITCHELL J MARUTSUKA K MITCHELL JJ SOBEL BE FUJII S
Citation: T. Sakamoto et al., TUMOR-NECROSIS-FACTOR-ALPHA AND INSULIN INDUCE PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 IN ADIPOCYTES, Journal of the American College of Cardiology, 31(2), 1998, pp. 3-3
HYALURONAN-INDUCED MODIFICATION OF HUMAN AORTIC SMOOTH-MUSCLE CELL EXPRESSION OF FIBRINOLYTIC SYSTEM PROTEINS AND ITS IMPLICATIONS FOR VASCULOPATHY IN DIABETICS
Authors: MARUTSUKA K WOODCOCKMITCHELL J SAKAMOTO T SOBEL BE FUJII S
Citation: K. Marutsuka et al., HYALURONAN-INDUCED MODIFICATION OF HUMAN AORTIC SMOOTH-MUSCLE CELL EXPRESSION OF FIBRINOLYTIC SYSTEM PROTEINS AND ITS IMPLICATIONS FOR VASCULOPATHY IN DIABETICS, Journal of the American College of Cardiology, 31(2), 1998, pp. 105-105
LOVASTATIN INHIBITS PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 PRODUCTIONBY ADIPOCYTES
Authors: SAKAMOTO T WOODCOCKMITCHELL J MARUTSUKA K SOBEL BE FUJII S
Citation: T. Sakamoto et al., LOVASTATIN INHIBITS PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 PRODUCTIONBY ADIPOCYTES, Journal of the American College of Cardiology, 31(2), 1998, pp. 468-468
FIBRIN-RICH AND PLATELET-RICH THROMBUS FORMATION ON NEOINTIMA - RECOMBINANT TISSUE FACTOR PATHWAY INHIBITOR PREVENTS FIBRIN FORMATION AND NEOINTIMAL DEVELOPMENT FOLLOWING REPEATED BALLOON INJURY OF RABBIT AORTA
Authors: ASADA Y HARA S TSUNEYOSHI A HATAKEYAMA K KISANUKI A MARUTSUKA K SATO Y KAMIKUBO Y SUMIYOSHI A
Citation: Y. Asada et al., FIBRIN-RICH AND PLATELET-RICH THROMBUS FORMATION ON NEOINTIMA - RECOMBINANT TISSUE FACTOR PATHWAY INHIBITOR PREVENTS FIBRIN FORMATION AND NEOINTIMAL DEVELOPMENT FOLLOWING REPEATED BALLOON INJURY OF RABBIT AORTA, Thrombosis and haemostasis, 80(3), 1998, pp. 506-511
EXPRESSION OF TISSUE FACTOR IN THE RABBIT AORTA AFTER BALLOON INJURY
Authors: HATAKEYAMA K ASADA Y MARUTSUKA K KATAOKA H SATO Y SUMIYOSHI A
Citation: K. Hatakeyama et al., EXPRESSION OF TISSUE FACTOR IN THE RABBIT AORTA AFTER BALLOON INJURY, Atherosclerosis (Amsterdam), 139(2), 1998, pp. 265-271
INCREASED PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 IN CORONARY-ARTERY ATHERECTOMY SPECIMENS FROM TYPE-2 DIABETIC COMPARED WITH NONDIABETIC PATIENTS - A POTENTIAL FACTOR PREDISPOSING TO THROMBOSIS AND ITS PERSISTENCE
Authors: SOBEL BE WOODCOCKMITCHELL J SCHNEIDER DJ HOLT RE MARUTSUKA K GOLD H
Citation: Be. Sobel et al., INCREASED PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 IN CORONARY-ARTERY ATHERECTOMY SPECIMENS FROM TYPE-2 DIABETIC COMPARED WITH NONDIABETIC PATIENTS - A POTENTIAL FACTOR PREDISPOSING TO THROMBOSIS AND ITS PERSISTENCE, Circulation, 97(22), 1998, pp. 2213-2221
INDUCTION OF PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 AND TYPE-1 COLLAGEN EXPRESSION IN RAT CARDIAC MICROVASCULAR ENDOTHELIAL-CELLS BY INTERLEUKIN-1 AND ITS DEPENDENCE ON OXYGEN-CENTERED FREE-RADICALS
Authors: OKADA H WOODCOCKMITCHELL J MITCHELL J SAKAMOTO T MARUTSUKA K SOBEL BE FUJII S
Citation: H. Okada et al., INDUCTION OF PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 AND TYPE-1 COLLAGEN EXPRESSION IN RAT CARDIAC MICROVASCULAR ENDOTHELIAL-CELLS BY INTERLEUKIN-1 AND ITS DEPENDENCE ON OXYGEN-CENTERED FREE-RADICALS, Circulation, 97(21), 1998, pp. 2175-2182
TUMOR-NECROSIS-FACTOR-ALPHA AND INSULIN INCREASE PLASMINOGEN-ACTIVATOR INHIBITOR-1 PRODUCTION IN ADIPOCYTES
Authors: SAKAMOTO T WOODCOCKMITCHELL J MARUTSUKA K SOBEL BE FUJII S
Citation: T. Sakamoto et al., TUMOR-NECROSIS-FACTOR-ALPHA AND INSULIN INCREASE PLASMINOGEN-ACTIVATOR INHIBITOR-1 PRODUCTION IN ADIPOCYTES, Journal of the American College of Cardiology, 29(2), 1997, pp. 91959-91959
TISSUE FACTOR PATHWAY INHIBITOR INHIBITS AORTIC SMOOTH-MUSCLE CELL-MIGRATION INDUCED BY TISSUE FACTOR FACTOR VIIA COMPLEX
Authors: SATO Y ASADA Y MARUTSUKA K HATAKEYAMA K KAMIKUBO Y SUMIYOSHI A
Citation: Y. Sato et al., TISSUE FACTOR PATHWAY INHIBITOR INHIBITS AORTIC SMOOTH-MUSCLE CELL-MIGRATION INDUCED BY TISSUE FACTOR FACTOR VIIA COMPLEX, Thrombosis and haemostasis, 78(3), 1997, pp. 1138-1141
POLARIZED DEUTERON BEAM ACCELERATION AT THE KEK-PS
Authors: SATO H TOYAMA T SHOJI Y SHIRAKATA M MARUTSUKA K YOSHII M TAKANO S ARAKAWA D TAKASAKI E ADACHI T KINSHO M TAKAGI A IKEGAMI K MACHIDA S IGARASHI Z MORI Y ARVIEUX J FUJIEDA M IWATA T HAYASHI N KAGEYA T FUKUI S HORIKAWA N MATSUDA T KOBA K TAKAHASHI M HASEGAWA T
Citation: H. Sato et al., POLARIZED DEUTERON BEAM ACCELERATION AT THE KEK-PS, Nuclear instruments & methods in physics research. Section A, Accelerators, spectrometers, detectors and associated equipment, 385(3), 1997, pp. 391-397
INTRAVENOUS-INJECTION OF SONICATED BLOOD INDUCES PULMONARY MICROTHROMBOEMBOLISM IN RABBITS WITH LIGATION OF THE SPLENIC ARTERY
Authors: KISANUKI A KIETTHUBTHEW S ASADA Y MARUTSUKA K FUNAHARA Y SUMIYOSHI A
Citation: A. Kisanuki et al., INTRAVENOUS-INJECTION OF SONICATED BLOOD INDUCES PULMONARY MICROTHROMBOEMBOLISM IN RABBITS WITH LIGATION OF THE SPLENIC ARTERY, Thrombosis research, 85(2), 1997, pp. 95-103
EXPRESSION OF TISSUE FACTOR AND TISSUE FACTOR PATHWAY INHIBITOR IN RAT LUNGS WITH LIPOPOLYSACCHARIDE-INDUCED DISSEMINATED INTRAVASCULAR COAGULATION
Authors: HARA S ASADA Y HATAKEYAMA K MARUTSUKA K SATO Y KISANUKI A SUMIYOSHI A
Citation: S. Hara et al., EXPRESSION OF TISSUE FACTOR AND TISSUE FACTOR PATHWAY INHIBITOR IN RAT LUNGS WITH LIPOPOLYSACCHARIDE-INDUCED DISSEMINATED INTRAVASCULAR COAGULATION, Laboratory investigation, 77(6), 1997, pp. 581-589
TISSUE FACTOR PATHWAY INHIBITOR INHIBITS AORTIC SMOOTH-MUSCLE CELL-MIGRATION INDUCED BY TISSUE FACTOR FACTOR VIIA COMPLEX
Authors: SATO Y ASADA Y MARUTSUKA K HATAKEYAMA K SUMIYOSHI A
Citation: Y. Sato et al., TISSUE FACTOR PATHWAY INHIBITOR INHIBITS AORTIC SMOOTH-MUSCLE CELL-MIGRATION INDUCED BY TISSUE FACTOR FACTOR VIIA COMPLEX, Atherosclerosis, 134(1-2), 1997, pp. 195-195
EXPRESSION OF TISSUE FACTOR IN ATHEROSCLEROTIC LESIONS
Authors: HATAKEYAMA K ASADA Y MARUTSUKA K SATO Y SUMIYOSHI A
Citation: K. Hatakeyama et al., EXPRESSION OF TISSUE FACTOR IN ATHEROSCLEROTIC LESIONS, Atherosclerosis, 134(1-2), 1997, pp. 250-251
LOCALIZATION AND ACTIVITY OF TISSUE FACTOR IN HUMAN AORTIC ATHEROSCLEROTIC LESIONS
Authors: HATAKEYAMA K ASADA Y MARUTSUKA K SATO Y KAMIKUBO Y SUMIYOSHI A
Citation: K. Hatakeyama et al., LOCALIZATION AND ACTIVITY OF TISSUE FACTOR IN HUMAN AORTIC ATHEROSCLEROTIC LESIONS, Atherosclerosis, 133(2), 1997, pp. 213-219
SYNERGISTIC AUGMENTATION OF EXPRESSION OF PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 BY INSULIN AND TNF-ALPHA IN ADIPOCYTES - A POTENTIAL LINK BETWEEN VASCULOPATHY AND THE INSULIN-RESISTANCE TYPICAL OF OBESITY
Authors: SAKAMOTO T WOODCOCKMITCHELL J MARUTSUKA K SOBEL BE FUJI S
Citation: T. Sakamoto et al., SYNERGISTIC AUGMENTATION OF EXPRESSION OF PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 BY INSULIN AND TNF-ALPHA IN ADIPOCYTES - A POTENTIAL LINK BETWEEN VASCULOPATHY AND THE INSULIN-RESISTANCE TYPICAL OF OBESITY, Circulation, 96(8), 1997, pp. 3046-3046
DIFFERENTIAL EXPRESSION OF FIBRINOLYTIC SYSTEM PROTEINS IN CORONARY ATHEROMA FROM TYPE-II DIABETIC AND NON DIABETIC SUBJECTS
Authors: WOODCOCKMITCHELL J MARUTSUKA K HOLT RE GOLD HK SOBEL BE
Citation: J. Woodcockmitchell et al., DIFFERENTIAL EXPRESSION OF FIBRINOLYTIC SYSTEM PROTEINS IN CORONARY ATHEROMA FROM TYPE-II DIABETIC AND NON DIABETIC SUBJECTS, Circulation, 96(8), 1997, pp. 3302-3302
TISSUE FACTOR INDUCES MIGRATION OF CULTURED AORTIC SMOOTH-MUSCLE CELLS
Authors: SATO Y ASADA Y MARUTSUKA K HATAKEYAMA K SUMIYOSHI A
Citation: Y. Sato et al., TISSUE FACTOR INDUCES MIGRATION OF CULTURED AORTIC SMOOTH-MUSCLE CELLS, Thrombosis and haemostasis, 75(3), 1996, pp. 389-392
PROGNOSTIC VALUE OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR IN PATIENTS WITH SUPERFICIAL BLADDER-CANCER
Authors: HASUI Y MARUTSUKA K ASADA Y OSADA Y
Citation: Y. Hasui et al., PROGNOSTIC VALUE OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR IN PATIENTS WITH SUPERFICIAL BLADDER-CANCER, Urology, 47(1), 1996, pp. 34-37
GANGLIONEUROBLASTOMA OF THE THYMUS - AN ADULT CASE WITH THE SYNDROME OF INAPPROPRIATE SECRETION OF ANTIDIURETIC-HORMONE
Authors: ASADA Y MARUTSUKA K MITSUKAWA T KURIBAYASHI T TANIGUCHI S SUMIYOSHI A
Citation: Y. Asada et al., GANGLIONEUROBLASTOMA OF THE THYMUS - AN ADULT CASE WITH THE SYNDROME OF INAPPROPRIATE SECRETION OF ANTIDIURETIC-HORMONE, Human pathology, 27(5), 1996, pp. 506-509
EFFECTS OF INFLATION PRESSURE OF BALLOON CATHETER ON VASCULAR INJURIES AND SUBSEQUENT DEVELOPMENT OF INTIMAL HYPERPLASIA IN RABBIT AORTA
Authors: ASADA Y KISANUKI A TSUNEYOSHI A MARUTSUKA K HATAKEYAMA K SUMIYOSHI A
Citation: Y. Asada et al., EFFECTS OF INFLATION PRESSURE OF BALLOON CATHETER ON VASCULAR INJURIES AND SUBSEQUENT DEVELOPMENT OF INTIMAL HYPERPLASIA IN RABBIT AORTA, Atherosclerosis, 121(1), 1996, pp. 45-53
PULMONARY TUMOR THROMBOTIC MICROANGIOPATHY
Authors: SATO Y MARUTSUKA K ASADA Y YAMADA M SETOGUCHI T SUMIYOSHI A
Citation: Y. Sato et al., PULMONARY TUMOR THROMBOTIC MICROANGIOPATHY, Pathology international, 45(6), 1995, pp. 436-440
EFFECTS OF SURAMIN ON METASTATIC ABILITY, PROLIFERATION, AND PRODUCTION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-2 IN HUMAN RENAL-CELL CARCINOMA CELL-LINE SN12C-PM6
Authors: MARUTSUKA K HASUI Y ASADA Y NAITO S OSADA Y SUMIYOSHI A
Citation: K. Marutsuka et al., EFFECTS OF SURAMIN ON METASTATIC ABILITY, PROLIFERATION, AND PRODUCTION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-2 IN HUMAN RENAL-CELL CARCINOMA CELL-LINE SN12C-PM6, Clinical & experimental metastasis, 13(2), 1995, pp. 116-122
RELATIONSHIP BETWEEN SERUM PROSTATE-SPECIFIC ANTIGEN AND HISTOLOGICALPROSTATITIS IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA
Authors: HASUI Y MARUTSUKA K ASADA Y IDE H NISHI S OSADA Y
Citation: Y. Hasui et al., RELATIONSHIP BETWEEN SERUM PROSTATE-SPECIFIC ANTIGEN AND HISTOLOGICALPROSTATITIS IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA, The Prostate, 25(2), 1994, pp. 91-96
Risultati: 1-25 | 26-29